🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsCardiovascular OutcomesSELECT trial: 20% MACE reduction — looking for input Page 5

SELECT trial: 20% MACE reduction — looking for input

TinaHashiRN Thu, Oct 9, 2025 at 9:06 AM 29 replies 1,384 viewsPage 5 of 6
fiona_VT
Member
178
890
Dec 2024
Vermont
Oct 9, 2025 at 4:11 PM#21

SleepFixSam — that is really helpful context on SELECT trial 20% MACE. Follow-up question: how long did you wait before increasing your dose?

I am in a similar situation (week 4) and trying to set realistic expectations.

12 17mark_tokyo, hans_munich, jason_sac26 and 9 others
Reply Quote Save Share Report
anders_CPH
Senior Member
1,567
7,234
Feb 2024
Copenhagen, DK
Oct 9, 2025 at 4:28 PM#22

To answer NurseLeah_Nash's question specifically:

From a clinical standpoint, SELECT trial 20% MACE is a reasonable concern that deserves a thorough answer.

The short answer: the evidence supports this approach for most patients.

The longer answer involves reviewing the specific clinical trial data relevant to your question, which I am happy to elaborate on if helpful.

48 13MariaRD, AussieAnna, BethLabQueen and 45 others
Reply Quote Save Share Report
PurityPaulOR
Senior Member
1,890
7,890
Mar 2024
Oregon
Oct 9, 2025 at 4:45 PM#23

Thank you fiona_VT! This is incredibly helpful. Taking this to my next appointment. 🙏

Last edited: Oct 9, 2025 at 7:45 PM
27 4Admin, Dr.Martinez, mike_mod and 24 others
Reply Quote Save Share Report

Janoshik Analytical — Independent Testing

Trusted third-party HPLC & mass spectrometry analysis. Verify peptide purity with the lab the community relies on. Independent. Accurate. Transparent.

Verify Your Peptides
HPLC_Greg
Senior Member
1,890
8,901
Feb 2024
Research Triangle, NC
Oct 9, 2025 at 5:02 PM#24

Relevant to SELECT trial 20% MACE — here is my latest bloodwork comparison:

Key improvements: A1C 8.0% → 5.3%, triglycerides 215 → 115 mg/dL, hsCRP 6.0 → 0.9 mg/L. All on tirzepatide for 7 months.

The inflammatory marker drop is what impresses me most. Consistent with the SELECT trial's cardiovascular findings.

21 13Dr.MetabolicMD, RetaRick_CA, JenPlateau and 18 others
Reply Quote Save Share Report
steve_okc
Member
489
2,123
Jul 2024
Oklahoma City, OK
Oct 9, 2025 at 5:19 PM#25

Slightly tangential to SELECT trial 20% MACE but fiona_VT reminded me — has anyone else noticed changes in their alcohol tolerance?

I know it is not exactly on-topic but it seems related enough to ask here rather than starting a new thread. Apologies if this has been covered — I did search first.

Last edited: Oct 9, 2025 at 9:19 PM
45 18KetoKyle, CanadaChris, ZaraB_AL and 42 others
Reply Quote Save Share Report

Similar Threads

SELECT trial: 20% MACE reduction — mechanistic deep dive7 replies
Semaglutide cardiovascular benefit independent of weight loss11 replies
STEP-HFpEF: semaglutide in heart failure with preserved EF15 replies
GLP-1 and arterial inflammation — hsCRP and IL-6 reduction data18 replies
Lp(a) on GLP-1 agonists — any impact on this risk factor?8 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register